Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer


Dogan A., Demirci S., Telci D., CANIKYAN S., KONGUR M., DEDE B. , ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.50, sa.2, ss.247-255, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Konu: 2
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s11255-017-1782-9
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Sayfa Sayıları: ss.247-255

Özet

Renal cell carcinoma (RCC) accounts for approximately 80% of the primary renal cancers, and current treatment strategies are not sufficient to provide a certain solution. Since there are not many treatment options, interest in discovery of alternative drugs has increased.